VOR BIOPHARMA INC - COMMON STOCK (VOR)

CUSIP: 929033108

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
48,114,688
Total 13F shares
60,946,605
Share change
+13,019,348
Total reported value
$67,648,215
Put/Call ratio
10%
Price per share
$1.11
Number of holders
51
Value change
+$16,089,562
Number of buys
18
Number of sells
31

Security key

929033108

Report period

Q4 2024

Institutions

51

Top holders

10

Top shareholders of VOR - VOR BIOPHARMA INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
47%
22,748,880
$15,924,216 30 Sep 2024
13F
FMR LLC
13F
Company
15%
7,071,110
$4,949,777 30 Sep 2024
13F
5AM Venture Management, LLC
13F
Company
13%
6,361,723
$4,453,206 30 Sep 2024
13F
Hudson Bay Capital Management LP
13F
Company
5.1%
2,466,236
$1,726,365 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
4.1%
1,954,285
$1,367,999 30 Sep 2024
13F
COWEN AND COMPANY, LLC
13F
Company
2.5%
1,220,590
$854,413 30 Sep 2024
13F
JOHNSON & JOHNSON
13F
Company
2.2%
1,074,658
$752,261 30 Sep 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.6%
756,011
$529,208 30 Sep 2024
13F
Sarissa Capital Management LP
13F
Company
1.3%
618,000
$432,600 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
1%
487,654
$341,359 30 Sep 2024
13F
MAI Capital Management
13F
Company
0.99%
475,891
$333,124 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.88%
422,143
$295,568 30 Sep 2024
13F
Ensign Peak Advisors, Inc
13F
Company
0.68%
329,378
$230,565 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.63%
303,825
$212,678 30 Sep 2024
13F
EXCHANGE TRADED CONCEPTS, LLC
13F
Company
0.34%
165,805
$116,063 30 Sep 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.29%
137,134
$95,994 30 Sep 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.28%
135,900
$95,130 30 Sep 2024
13F
MARSHALL WACE, LLP
13F
Company
0.24%
116,635
$81,645 30 Sep 2024
13F
STATE STREET CORP
13F
Company
0.24%
115,934
$81,154 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.24%
113,365
$79,356 30 Sep 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.17%
81,305
$55,000 30 Sep 2024
13F
Rosalind Advisors, Inc.
13F
Company
0.16%
76,685
$53,680 30 Sep 2024
13F
Bollard Group LLC
13F
Company
0.12%
55,555
$39,000 30 Sep 2024
13F
LMR Partners LLP
13F
Company
0.11%
51,111
$35,778 30 Sep 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.1%
50,300
$35,210 30 Sep 2024
13F
HSBC HOLDINGS PLC
13F
Company
0.09%
44,728
$32,459 30 Sep 2024
13F
NOMURA HOLDINGS INC
13F
Company
0.09%
41,495
$29,047 30 Sep 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.06%
30,825
$21,578 30 Sep 2024
13F
Point72 Asia (Singapore) Pte. Ltd.
13F
Company
0.06%
29,530
$20,671 30 Sep 2024
13F
Laurion Capital Management LP
13F
Company
0.06%
28,981
$20,287 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.06%
28,227
$19,759 30 Sep 2024
13F
Ground Swell Capital, LLC
13F
Company
0.05%
26,103
$18,272 30 Sep 2024
13F
MONEY CONCEPTS CAPITAL CORP
13F
Company
0.05%
25,000
$17,500 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.05%
24,448
$17,114 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.05%
24,219
$16,953 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.04%
17,792
$12,454 30 Sep 2024
13F
UNITED BANK
13F
Company
0.03%
15,300
$10,710 30 Sep 2024
13F
GRIMES & Co WEALTH MANAGEMENT, LLC
13F
Company
0.03%
15,142
$10,599 30 Sep 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.03%
13,761
$9,633 30 Sep 2024
13F
Chicago Partners Investment Group LLC
13F
Company
0.03%
13,593
$9,549 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.03%
12,038
$8,427 30 Sep 2024
13F
BARCLAYS PLC
13F
Company
0.02%
11,024
$7,717 30 Sep 2024
13F
CHIRON CAPITAL MANAGEMENT, LLC
13F
Company
0.02%
11,000
$7,700 30 Sep 2024
13F
Catalyst Funds Management Pty Ltd
13F
Company
0.02%
9,800
$6,860 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
5,871
$4,110 30 Sep 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0.01%
5,053
$3,000 30 Sep 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
4,298
$3,009 30 Sep 2024
13F
FEDERATED HERMES, INC.
13F
Company
0.01%
3,759
$2,631 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
0%
713
$499 30 Sep 2024
13F
Arax Advisory Partners
13F
Company
0%
528
$370 30 Sep 2024
13F

Institutional Holders of VOR BIOPHARMA INC - COMMON STOCK (VOR) as of Q4 2024

As of 31 Dec 2024, VOR BIOPHARMA INC - COMMON STOCK (VOR) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 60,946,605 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., FMR LLC, 5AM Venture Management, LLC, VANGUARD GROUP INC, JOHNSON & JOHNSON, Lynx1 Capital Management LP, Sarissa Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 51 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
53
Q4 2024 holders
51
Holder diff
-2
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .